Home
»
Press Room
»
Specialty Enzymes Market Size To Reach $8.89Bn By 2030

Specialty Enzymes Market Size To Reach $8.89 Billion By 2030

June 2025 | Report Format: Electronic (PDF)

Specialty Enzymes Market Growth & Trends

The global specialty enzymes market size is expected to reach USD 8.89 billion by 2030, registering a CAGR of 6.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. This is attributable to the specific yield optimization and catalytic reaction properties of specialty enzymes.

Pharmaceutical manufacturers across the globe have incorporated these specialty enzymes on account of their expanding applications particularly in processing fine chemicals and pure pharmaceutical drugs. The shift in trend towards the adoption of specialty enzymes in order to reduce reliance on conventional enzymes has been observed in the last few years and hence these enzymes are expected to penetrate the overall industry growth. Specialty enzymes are widely used to manufacture drugs to treat some fatal diseases such as cardiovascular diseases, cancer, and pain caused by age, asthma, hay fever, and lysosomal storage disorders in the pharmaceutical industry. The increasing prevalence of such diseases coupled with the growing geriatric population particularly in the U.S., Europe, and Japan is also expected to have a positive influence on industry growth.

Growth of the global pharmaceutical industry, growing number of biotechnology R&D, and advancement in enzyme engineering & green chemistry are expected to fuel the market over the forecast period. Difficulty in maintaining pH and operational temperature of specialty enzymes is expected to remain a key concern for key players. Legal & ethical issues coupled to lack of awareness among consumers regarding the benefits of specialty enzymes particularly in developing countries is also expected to pose threat to the market growth. However, the growing industrialization rate and advanced technologies adopted in the pharmaceutical industry in emerging markets of BRIC nations is expected to hold future opportunities for industry participants.

North America emerged as the largest regional specialty enzyme market owing to the presence of niche consumers and advanced technologies. An increase in population and growth in disposable income among consumers in emerging markets of China and India is expected to drive the industry demand in the Asia Pacific region. China, India, and Brazil are expected to be the most lucrative regional markets for specialty enzymes. Some of the key specialty enzyme manufacturers include Advanced Enzyme Technology Ltd. Affymetrix Inc., Advanced Enzyme Technology Ltd., Amano Enzyme Inc., Bbi Enzymes Ltd., Basf, Codexis Inc., Nagase & Co. Ltd., Life Technologies, Roche Holding Ag., and Sanofi S.A among others.

key Request a free sample copy or view report summary: Specialty Enzymes Market Report

Specialty Enzymes Market Report Highlights

The carbohydrase segment dominated the market with the largest revenue share of 37.6% in 2024, fueled by rising consumer demand for dietary supplements and digestive health products that rely heavily on carbohydrase enzymes. The proteases segment is anticipated to grow at a significant CAGR of 6.5% over the forecast period.
The pharmaceutical segment held the largest revenue share in 2024, propelled by rising population, growing consumer demand, and increasing disease awareness. The biocatalyst segment is projected to be the fastest-growing segment in the specialty enzymes industry from 2025 to 2030.
The microorganisms segment accounted for the largest market share in 2024 due to the widespread use of amylases in the biotechnology and pharmaceutical industries. The animal segment is projected to grow at the fastest CAGR over the forecast period.
North America specialty enzymes market dominated the global market with the largest revenue share of 41.9% in 2024. The U.S. specialty enzymes market held the largest share in 2024, owing to increased demand for specialty enzymes in pharmaceuticals and diagnostics.